MARK E ALLARA MD NPI 1659457984

NPI Details

Mark E Allara, MD is a family medicine in Middleton, MA with 31 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. Mark E Allara, MD NPI is 1659457984. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURGEONS
Graduation Year:1994

The provider's business location address is:

147 S MAIN ST
MIDDLETON, MA
ZIP 01949-446
Phone: (978) 774-2555
Fax: (978) 774-8715

The NPI 1659457984 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Liver function blood test panel (HCPCS:80076)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Hemoglobin a1c level (HCPCS:83036)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Iron level (HCPCS:83540)
• Folic acid level, serum (HCPCS:82746)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Ferritin (blood protein) level (HCPCS:82728)
• Vitamin d-3 level (HCPCS:82306)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Iron binding capacity (HCPCS:83550)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Urine microalbumin (protein) level (HCPCS:82043)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• X-ray of chest, 2 views (HCPCS:71046)
• Established patient home visit, typically 25 minutes (HCPCS:99348)
• Established patient home visit, typically 40 minutes (HCPCS:99349)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Magnesium level (HCPCS:83735)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
• Ultrasound scan of abdominal aorta (HCPCS:76706)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Ultrasound scan of head and neck soft tissue (HCPCS:76536)
• Follow-up psychiatric collaborative care management, subsequent calendar month, first 60 minutes (HCPCS:99493)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Complete ultrasound scan of abdomen (HCPCS:76700)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• X-ray of knee, 1-2 views (HCPCS:73560)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Testosterone (hormone) level, free (HCPCS:84402)
• Removal of impacted ear wax (HCPCS:69210)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Established patient home visit, typically 15 minutes (HCPCS:99347)
• Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment (HCPCS:99453)
• Bilirubin level, direct (HCPCS:82248)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Limited ultrasound scan of abdomen (HCPCS:76705)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Established patient home visit, typically 1 hour (HCPCS:99350)
• Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report (HCPCS:G0403)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Pneumococcal vaccine, 13-valent (HCPCS:90670)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• X-ray of abdomen, 1 view (HCPCS:74018)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• X-ray of ankle, minimum of 3 views (HCPCS:73610)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Assessment of emotional or behavioral problems (HCPCS:96127)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Initial psychiatric collaborative care management, first calendar month, first 70 minutes (HCPCS:99492)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Blood potassium level (HCPCS:84132)
• New patient home visit, typically 45 minutes (HCPCS:99343)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 10/30/2006 and was last updated on 2/11/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.